Suppr超能文献

病毒在炎症性肠病发病机制中的作用:Toll样受体7/8/3的作用

Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3.

作者信息

Asadzadeh Aghdaei Hamid, Jamshidi Negar, Chaleshi Vahid, Jamshidi Nazanin, Sadeghi Amir, Zali Mohammad Reza

机构信息

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Gastroenterol Hepatol Bed Bench. 2021 Fall;14(4):295-303.

Abstract

The pathogenesis of inflammatory bowel disease (IBD) is influenced by immune system malfunction, particularly innate immune receptors such as toll-like receptors. Furthermore, it is critical to investigate the extremely close association between viruses and IBD incidence. Toll-like receptors (TLRs) 3, 5, and 7 are involved in antiviral immune responses. Finding a relationship between TLR-related virus and IBD is important not only for understanding the disease pathogenesis, but also for developing effective therapies. It has been shown that influenza is expressed more severely in patients with IBD who use immune system inhibitors, and the influenza vaccine is less effective in these patients. In dendritic cells, TLR7 and TLR8 regulate the production of interferons (IFNs) and inflammatory mediators. COVID-19 causes the production of IL-6, possibly due to the induction of TLR pathways. TLR activation by SARS-CoV-2 causes inflammation and IL-1 production, which induces the production of IL-6. Understanding TLR-associated viruses' molecular mechanisms can greatly help improve the quality of life of people with IBD. Therefore, the present study reviewed the role of TLR7, 8, and 3 in inflammatory bowel disease as well as their association with viral infections and evaluated different antagonists for the treatment of IBD.

摘要

炎症性肠病(IBD)的发病机制受免疫系统功能异常影响,尤其是像Toll样受体这类天然免疫受体。此外,研究病毒与IBD发病率之间极为密切的关联至关重要。Toll样受体(TLRs)3、5和7参与抗病毒免疫反应。发现TLR相关病毒与IBD之间的关系不仅对于理解疾病发病机制很重要,而且对于开发有效治疗方法也很重要。研究表明,使用免疫系统抑制剂的IBD患者流感病情更严重,且流感疫苗对这些患者效果较差。在树突状细胞中,TLR7和TLR8调节干扰素(IFNs)和炎症介质的产生。新型冠状病毒肺炎(COVID-19)可能由于TLR途径的诱导导致白细胞介素-6(IL-6)的产生。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)激活TLR会引起炎症和IL-1的产生,进而诱导IL-6的产生。了解TLR相关病毒的分子机制能够极大地帮助改善IBD患者的生活质量。因此,本研究综述了TLR7、8和3在炎症性肠病中的作用及其与病毒感染的关联,并评估了用于治疗IBD的不同拮抗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d4e/8514217/b582874a2fa9/GHFBB-14-295-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验